Five Biotechs Poised to Advance Their Rare Disease Programs in 2020

Published on : January 28, 2020January 28, 2020 Published by : Steven Surdez

Five Biotechs Poised to Advance Their Rare Disease Programs in 2020 On the cusp of rare disease month, we’re checking in with Maryland biotech companies at the forefront of rare [….]

2019’s Top 10 Most Read Biotech News Stories from the BioHealth Capital Region

Published on : December 23, 2019January 14, 2020 Published by : Steven Surdez

Top 10 Biotech News Stories from 2019 from the BioHealth Capital Region on biobuzz.io

Why The Next Biotech Boom Could be Sparked by New Therapies for Neurological Disorders

Published on : December 3, 2019December 7, 2019 Published by : Sharlene Brown, PhD

Why The Next Biotech Boom Could be Sparked by New Therapies for Neurological Disorders Several Maryland Biotech Firms Are Blazing New Trails in Gene Therapy, Drugs and Diagnostics for Neurological [….]

Bio Innovation Conference

Published on : October 7, 2019July 24, 2019 Published by : Chris Frew

Presented by Maryland Life Sciences (MDLS), a division of the Maryland Tech Council, the Bio Innovation Conference showcases Maryland’s innovation and success in the life sciences industry. The Bio Innovation [….]

Why Developing Cures for Rare Disease Isn’t So Rare Anymore

Published on : September 3, 2019September 5, 2019 Published by : Steven Surdez

Why Developing Cures for Rare Disease Isn’t So Rare Anymore These Six Maryland Biotech Companies Are Seeing Success in Targeting Rare Diseases September 3, 2019 Groundbreaking technology and scientific advancements, [….]

Five Companies That Are Changing the Landscape for Cell and Gene Therapy

Published on : June 4, 2019May 28, 2020 Published by : Chris Frew

Five Cell and Gene Therapy Companies that Are Changing the Landscape of the Field

Industry Leaders Outline Five Important Elements Impacting Rare Disease Drug Development

Published on : April 30, 2019July 18, 2019 Published by : Steven Surdez

BioBuzz Panel on Drug Development in Rare Diseases with regional leaders from AstraZeneca, REGENXBIO, American Gene Technologies, GeneDx and Jeeva Informatics

Leaders Discuss Top Priorities for Workforce & Infrastructure to Grow BioHealth Capital Region

Published on : April 3, 2019April 3, 2019 Published by : Steven Surdez

Leaders Discuss Top Priorities for Workforce & Infrastructure to Grow BioHealth Capital Region April 3, 2019 Scientists, engineers, life science executives, academics, government officials and other constituents recently gathered to [….]